Product
Supplier
Encyclopedia
Inquiry
Home > News > Pharma News > Catalent Bolsters Drug Development Capabilities

Catalent Bolsters Drug Development Capabilities

Contract Pharma 2018-04-25

Catalent Pharma Solutions has unveiled plans to invest $5 million in the creation of a new drug development center of excellence (CoE) at its Somerset, NJ facility and headquarters. The investment will see the site focus on preclinical to clinical phase 2b formulation, analytical, and manufacturing solutions for orally delivered small molecules. It will also build upon the site's expertise in the development of modified release formulation, bioavailability solutions, the application of OptiMelt hot melt extrusion (HME) technology, and its status as the company's CoE for handling potent compounds and controlled substances.

"This latest investment in Somerset will significantly strengthen our early development offering with focused formulation expertise and capacity for additional speed and flexibility," said Jonathan Arnold, president of Catalent's oral drug delivery business unit. "It is highly complementary to Catalent's West Coast facility in San Diego, CA and further positions Catalent as the strategic partner of choice for the early development of solid oral dose forms."

Catalent's 265,000 square-foot headquarters and development center in Somerset has a long track record of successfully developing, launching, and manufacturing many oral treatments for leading global innovators. The site features state-of-the-art analytical labs, pilot and clinical scale equipment including HME and fluid bed processing, and significant expertise in coating technologies, capsules, tablets, minitablets, and multi-particulates.

Catalent's early phase drug development sites are closely connected to Catalent's clinical supply services network, to optimize transition from finished dose manufacture to clinical packaging and distribution. In addition, the Somerset facility will offer seamless transfers to Catalent's integrated commercial manufacturing network in: Kansas City, MO; Winchester, KY; Swindon, UK; and Schorndorf, Germany, for later stage clinical trials using compatible, scalable equipment.

Disclaimer: ECHEMI reserves the right of final explanation and revision for all the information.

Looking for chemical products? Let suppliers reach out to you!

Comment
Comment
  • Life Sciences Industry Overview

    The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.
    Published in: June.2026

Trade Alert

Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.